Options
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with hiv-1 infection
Journal
AIDS
Journal Volume
36
Journal Issue
1
Pages
39-48
Date Issued
2022
Author(s)
Cahn P.
Sierra Madero J.
Arribas J.R.
Antinori A.
Ortiz R.
Clarke A.E.
Rockstroh J.K.
Girard P.-M.
Sievers J.
Man C.Y.
Urbaityte R.
Brandon D.J.
Underwood M.
Pappa K.A.
Curtis L.
Smith K.Y.
Gartland M.
Aboud M.
Van Wyk J.
Wynne B.
Publisher
Lippincott Williams and Wilkins
Type
journal article